{"database": "lobbying", "table": "lobbying_activities", "rows": [[843661, "e86c173c-11c0-4890-bfb1-0c0ac33ac481", "Q3", "APOTEX CORP.", 310973, "APOTEX CORP.", 2009, "third_quarter", "PHA", "S. 369, the Preserve Access to Affordable Pharmaceuticals Act\nHR 1706, the Protecting Consumer Access to Generic Drugs Act\nS. 1315, the Drug Price Competition Act of 2009\nHR 3200, Subtitle C - Food & Drug Administration, Section 2563, Protecting Consumer Access to Generic Drugs HR 3200, Subtitle C, Food & Drug Administration, Part 2, Biosimilars Section 2565, Licensure Pathway for Biosimilar Biological Products\nHR 1427, the Promoting Innovation and Access to Life Savings Medicine Act\nHR 1548, Pathway for Biosimilars Act", "Congressional Budget Office (CBO),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE", null, 150000, 0, 0, "2009-10-20T09:59:27-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["843661"], "units": {}, "query_ms": 0.8173109963536263, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}